Generative Artificial Intelligence Intervention and Individual Psychological Counseling on Emotional Distress in Young Adults
NCT ID: NCT06992180
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
222 participants
INTERVENTIONAL
2025-05-20
2025-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Generated AI-informed Intervention (Emohaa) vs Group ACT vs WL on Emotional Distress
NCT06735807
Testing the Effectiveness of AI Chatbots to Improve Public Knowledge and Attitudes Towards Depression
NCT06858371
Young People Aged 18-25 With Depression or Anxiety Mood Participate in an LLM-based Digital Dialogue Intervention Study
NCT06346496
AI Chatbots for Anxiety Mental Health Literacy
NCT07316374
Non-inferiority of Virtual vs. Traditional Methods in Adolescent Mental Health Literacy
NCT07238842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AI Chatbot Group: Participants will interact weekly with Emohaa via a WeChat-integrated interface for 30-minute sessions over a 6-week period. The chatbot uses fine-tuned large language models to simulate emotionally supportive conversations and provide personalized, non-directive psychological support.
Traditional Counseling Group: Participants will receive six weekly sessions (face-to-face or remote) with trained counselors using structured, supportive counseling protocols derived from cognitive-behavioral therapy (CBT).
Waitlist Control Group: Participants will not receive any intervention during the study period but will be offered access to Emohaa after study completion.
Assessment Schedule and Outcome Measures
Data will be collected via Wenjuanxing online survey links at six time points:
T1: Baseline (before intervention)
T2: After session 2
T3: After session 4
T4: Post-intervention (after session 6)
T5: 2-week follow-up
T6: 1-month follow-up
All outcome measures are validated self-report instruments with established psychometric properties in Chinese populations.
Primary Outcomes (T1-T6) PHQ-9: Patient Health Questionnaire for depressive symptoms
GAD-7: Generalized Anxiety Disorder Scale
ISI: Insomnia Severity Index (7 items)
Academic Burnout Scale (6 items)
Secondary Outcomes (T1-T6) ERQ: Emotion Regulation Questionnaire (10 items)
Loneliness Scale (3 items)
IUS-12: Intolerance of Uncertainty Scale
PSS-10: Perceived Stress Scale
GESS: General Self-Efficacy Scale (10 items)
Additional Measures (T2-T6) CSQ-8: Client Satisfaction Questionnaire
DWAI: Digital Working Alliance Inventory
Data Quality and Collection Procedures All data will be collected electronically using Wenjuanxing (问卷星), which provides timestamped, secure survey distribution and response logging. Participants will receive automatic reminders prior to each time point. The data collection team will perform regular checks to detect and manage missing or inconsistent entries.
To ensure the reliability and validity of the data collection process:
All measurement instruments are widely used, psychometrically validated scales in Chinese.
Survey completion will be monitored in real time.
Study staff will be trained in participant guidance and data integrity monitoring procedures.
Duplicate entries will be flagged using participant ID and contact verification protocols.
Random audits and outlier checks will be conducted at each time point to ensure data quality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Generative Artificial Intelligence Intervention Group
Participants will interact weekly with Emohaa via a WeChat-integrated interface for 30-minute sessions over a 6-week period. The chatbot uses fine-tuned large language models to simulate emotionally supportive conversations and provide personalized, non-directive psychological support.
Generative Artificial Intelligence Intervention
The intervention is delivered via a generative artificial intelligence platform called Emohaa. Participants will register and gain access to the platform prior to the start of the trial. Emohaa's responses are based on Hill's helping skills theory in psychology and are designed to simulate the basic communication strategies of a human counselor. The system demonstrates strong capabilities in active listening, emotional mirroring, and empathy, supporting users in understanding their own thoughts and feelings, learning to cope with emotional challenges, and achieving a more optimistic and positive mental and emotional state.
Individual Psychological Counseling Group
Participants will receive six weekly sessions (face-to-face or remote) with trained counselors using structured, supportive counseling protocols derived from cognitive-behavioral therapy (CBT).
Individual Psychological Counseling
Participants in the traditional counseling group will receive individual psychological counseling sessions conducted by certified psychotherapists.
Waiting List Group
Participants will not receive any intervention during the study period but will be offered access to Emohaa after study completion.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Generative Artificial Intelligence Intervention
The intervention is delivered via a generative artificial intelligence platform called Emohaa. Participants will register and gain access to the platform prior to the start of the trial. Emohaa's responses are based on Hill's helping skills theory in psychology and are designed to simulate the basic communication strategies of a human counselor. The system demonstrates strong capabilities in active listening, emotional mirroring, and empathy, supporting users in understanding their own thoughts and feelings, learning to cope with emotional challenges, and achieving a more optimistic and positive mental and emotional state.
Individual Psychological Counseling
Participants in the traditional counseling group will receive individual psychological counseling sessions conducted by certified psychotherapists.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suffering from emotional distress (PHQ-9 \> 14 or GAD-7 \> 12)
* Ability to use the mobile phone to interact with AI
* Consent to participate in the study
Exclusion Criteria
* Presence of psychotic symptoms (i.e., delusions)
* Serious substance use problems
* Other mental or physical illnesses requiring urgent medical assistance
* Received other psychological or pharmacological interventions in the last month.
15 Years
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Normal University
OTHER
China Agricultural University
OTHER
Qinghai University
OTHER
Central University of Finance and Economics, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yi Feng
Associate researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhihong Qiao, Doctor
Role: STUDY_DIRECTOR
Beijing Normal University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CUFE-20260518
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.